Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | HPGD | P15428 | 3/20 | 0.32 |
| ▸ | GLA | P06280 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.32 |
| ▸ | PRKDC | P78527 | 4/20 | 0.31 |
| ▸ | XRCC6 | P12956 | 1/20 | 0.31 |
| ▸ | XRCC5 | P13010 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 2/20 | 0.30 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23308818 | 0.94 | KDM4E (0.33) | SIGMAR1KDM4EHPGDGLAMAPT | |
| SCHEMBL15852019 | 0.90 | DYRK1A (0.35) | KDM4EHPGDMAPTHSD17B10L3MBTL1 | |
| SCHEMBL24655322 | 0.90 | CYP1A2 (0.33) | SIGMAR1KDM4EHPGDGLAMAPT | |
| SCHEMBL25642328 | 0.89 | AHR (0.32) | KDM4EHPGDGLAMAPTHSD17B10 | |
| SCHEMBL26489493 | 0.89 | PTPN1 (0.33) | KDM4EHPGDMAPTHSD17B10L3MBTL1 | |
| SCHEMBL27320224 | 0.89 | ALOX5 (0.43) | KDM4EHPGDMAPTPRKDCALOX5 | |
| SCHEMBL23348233 | 0.88 | DYRK1A (0.33) | KDM4EHPGDMAPTDYRK1AAHR | |
| SCHEMBL24657837 | 0.88 | AHR (0.32) | KDM4EHPGDGLAMAPTHSD17B10 | |
| SCHEMBL26061497 | 0.88 | CYP1A2 (0.35) | SIGMAR1KDM4EHPGDGLAMAPT | |
| SCHEMBL25902787 | 0.87 | ALDH1A1 (0.36) | SIGMAR1KDM4EHPGDGLAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230331689-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| US-20230331689-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331689-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, CYP1A1 | SIGMAR1 2290/4885KDM4E 2443/4885HPGD 1375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.